The leading source for credible citizen reporting

Report Your News
Take the tour...

This event is older than two months and is no longer active. Some links older than two months could be broken.

Report Your News

Click here to post a new related report

What is left at MDS?

Sacramento : CA : USA | 2 months ago  
Views: 0
W hile MDS impressed investors by selling its medical instruments division for a better-than-expected $650-million (U.S.), the company is now dogged by questions of what’s next. MDS, an underperformer in recent years, said Wednesday that it plans to focus on medical isotopes and is still trying...
  • Print
  • Share:
  • Share
  • Digg
  • Reddit
  • Facebook
  • Stumbleupon

Related Allvoices Contributions

News Stories
 
  • News Source: Kansas City Star | 2 months ago
    The McClatchy Co. said Friday it had been notified by the New York Stock Exchange that it was in compliance with the exchange’s continued listing requirements for share price.

    On Feb. 4, the exchange told McClatchy, parent company of 30...

  • News Source: Belleville News-Democrat | 2 months ago
    The McClatchy Company said Friday that the New York Stock Exchange has determined the company's share price has returned to levels necessary to remain on the exchange. Exchange regulators notified the newspaper company in February that its average...
  • News Source: Star Tribune | 2 months ago
    Fannie Mae, the government-backed mortgage company, said Friday it regained compliance with the New York Stock Exchange's minimum price standard for listing common stock. Fannie Mae was notified on Nov. 12, 2008 that it failed to satisfy one of the...
  • News Source: The Globe & Mail | 2 months ago
    W hile MDS impressed investors by selling its medical instruments division for a better-than-expected $650-million (U.S.), the company is now dogged by questions of what’s next. MDS, an underperformer in recent years, said Wednesday that it plans...
Most Popular Reports

Contributions

Help and Accounts


Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc 2008-2009. All rights reserved.